Medical Xpress

APRIL 11, 2023

A team of scientists from the Universities of Sheffield, Reading and University College London (UCL) and US-based biopharmaceutical company Neuresta have created a new, elongated botulinum neurotoxin which can alleviate chronic pain without risk of paralysis or addiction.

Botox 64

Botox Scientist 64

pharmaphorum

FEBRUARY 12, 2021

Ipsen’s John Chaddock tells us why the company is investing heavily in neurotoxin research and how he hopes to raise awareness among young scientists and the NHS. Injected neurotoxins can be incredibly potent in treating spasticity from neurological diseases, but the field doesn’t always get the attention it needs.

Botox 105

Botox Research Development Protein 105

XTalks

OCTOBER 4, 2024

Botulinum toxin (Botox) injections can temporarily reduce muscle spasticity by tightening muscles in specific areas. Muscle relaxants (e.g., baclofen, diazepam) can help reduce spasticity and are used to help relax muscles. Anticonvulsants are used to control seizures, which can be common in individuals with cerebral palsy.

Genetics 52

Genetics Botox Research Development 52

XTalks

AUGUST 2, 2023

percent increase since 2021, predominantly due to Botox sales for therapeutic uses. 2) Botox Therapeutic/Cosmetic Botox, or botulinum neurotoxin, is a neurotoxic protein produced by the Clostridium botulinum bacteria. Botox is also used as therapeutic treatments for neck spasms, excessive sweating, lazy eyes and migraines.

Sales 98

Sales Manufacturing FDA Approval Life Science 98